eSpCas9(1.1)-T2A-Puro Citations (5)
Originally described in: eSpCas9(1.1)-T2A-PuroUnpublished
Articles Citing eSpCas9(1.1)-T2A-Puro
Articles |
---|
Recharacterization of the mammalian cytosolic type 2 (R)-beta-hydroxybutyrate dehydrogenase as 4-oxo-l-proline reductase (EC 1.1.1.104). Kwiatkowski S, Bozko M, Zarod M, Witecka A, Kocdemir K, Jagielski AK, Drozak J. J Biol Chem. 2022 Mar;298(3):101708. doi: 10.1016/j.jbc.2022.101708. Epub 2022 Feb 10. PubMed |
Mapping of the regions implicated in nuclear localization of multi-functional DNA repair endonuclease XPF-ERCC1. Akahori R, Takamori C, Wakasugi M, Matsunaga T. Genes Cells. 2022 May;27(5):356-367. doi: 10.1111/gtc.12932. Epub 2022 Mar 8. PubMed |
Sequential and directional insulation by conserved CTCF sites underlies the Hox timer in stembryos. Rekaik H, Lopez-Delisle L, Hintermann A, Mascrez B, Bochaton C, Mayran A, Duboule D. Nat Genet. 2023 Jul;55(7):1164-1175. doi: 10.1038/s41588-023-01426-7. Epub 2023 Jun 15. PubMed |
Sirtuin 5-mediated deacetylation of TAZ at K54 promotes melanoma development. Kim G, Bhattarai PY, Lim SC, Lee KY, Choi HS. Cell Oncol (Dordr). 2023 Dec 19. doi: 10.1007/s13402-023-00910-w. PubMed |
Homozygous variant in translocase of outer mitochondrial membrane 7 leads to metabolic reprogramming and microcephalic osteodysplastic dwarfism with moyamoya disease. Li CY, Chen LW, Tsai MC, Chou YY, Lin PX, Chang YM, Hwu WL, Chien YH, Lin JL, Chen HA, Lee NC, Su PH, Hsieh TC, Klinkhammer H, Wang YC, Huang YT, Krawitz PM, Lin SH, Huang LLH, Chiang PM, Shih MH, Chen PC. EBioMedicine. 2024 Dec;110:105476. doi: 10.1016/j.ebiom.2024.105476. Epub 2024 Nov 29. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.